stella
beta
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer — Stella
Recruiting
Back to Metastatic Colorectal Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
View full record on ClinicalTrials.gov